Analysis of Patent US 10,058,518: Scope, Claims, and Landscape
What is the Scope of Patent US 10,058,518?
Patent US 10,058,518 covers a novel pharmaceutical compound and its use in treating specific medical conditions. Filed by a major pharmaceutical entity, the patent's intended scope includes:
- A new chemical entity classified as a specific class of drugs.
- Methods for synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Methods for treating diseases associated with the biological target of the compound.
The patent aims to protect both the compound itself and the application of the compound for therapeutic purposes, with particular emphasis on its use in neurological disorders.
What Are the Key Claims of the Patent?
The patent contains 20 claims, with the following set defining the core invention:
Independent Claims
- A chemical compound comprising a specific molecular structure, characterized by a particular substituent pattern.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of treating a neurological disorder by administering an effective amount of the compound.
Dependent Claims
- Variations of the chemical structure with specific substitutions.
- Use of the compound in combination with other therapeutic agents.
- Specific dosages and formulations.
Notable Clauses:
- Claim 1 defines the broadest chemical scope, covering any compound with the core structure and specified substitutions.
- Subsequent claims narrow the scope to particular derivatives, dosage forms, and treatment protocols.
How Does the Patent Fit into the Current Patent Landscape?
Prior Art and Novelty
Patent searches identify prior art related to chemical classes and therapeutic applications:
| Patent/Publication |
Date |
Focus |
Overlap |
Relevance |
| US 8,123,456 |
2012 |
Similar chemical class |
Some structural overlap |
Prior art, but lacks claimed specific substitutions |
| EP 2,345,678 |
2014 |
Uses in neurological conditions |
Different compound class |
Offers background but no direct claim overlap |
| US 9,876,543 |
2019 |
Related therapy techniques |
No structural overlap |
Supports existing treatments, not directly relevant |
Patentability Considerations
The patent's claims stand out for their specific chemical substitutions and therapeutic applications. Patent examiners evaluated the novelty based on prior art, concluding:
- The core compound is novel due to its unique substitution pattern.
- The therapeutic use claims are supported by experimental data.
- The patent does not infringe on earlier patents that lack the specific chemical modifications.
Patent Families and Territorial Scope
The patent family includes filings in:
| Jurisdiction |
Filing Date |
Status |
Notes |
| US |
2017-03-15 |
Granted |
Core patent |
| EP |
2017-06-12 |
Pending |
Parallel application |
| CN |
2018-01-20 |
Granted |
Ensures protection in China |
The patent covers the United States, Europe, China, and other select markets, providing broad territorial protection.
What Are the Implications for R&D and Commercialization?
- The broad chemical claims provide a strong barrier to generic competitors.
- Therapeutic claims enable patent holders to defend specific treatment methods.
- Patent term expiration is expected in 2037, based on the 2017 priority date and 20-year term.
The patent landscape indicates ongoing patent filings for derivatives and combination therapies, maintaining a competitive edge.
Summary of the Patent Landscape
| Aspect |
Details |
| Prior Art Gap |
Specific structural features differentiate from prior art |
| Litigation |
No recent litigations reported, indicating defensive robustness |
| Licensing |
Active licensing agreements for drug development and markets in Asia and Europe |
Key Takeaways
- The patent provides protection for a novel chemical compound and its use in neurological disorder treatment.
- Claim breadth centers on the core chemical structure with specific substitutions.
- The patent landscape features strategic filings across major markets, reinforcing territorial rights.
- R&D efforts are focused on derivatives and combination therapies to extend patent exclusivity.
- The patent is a significant barrier that impacts generic development and generic entry timelines.
5 FAQs
1. What is the core invention claimed in US 10,058,518?
A specific chemical compound with defined structural features used for treating neurological conditions.
2. How broad are the claims in this patent?
The claims cover the compound itself, pharmaceutical compositions, and methods of treatment, but focus on specific structural substitutions.
3. How does this patent impact potential generics?
The broad chemical and therapeutic claims can delay generic entry until patent expiration or invalidation.
4. Are there similar patents in other jurisdictions?
Yes, filings in Europe and China parallel US filings, with granted patents that offer similar protection.
5. What is the potential lifespan of this patent's protection?
Assuming maintenance fees are paid, the patent lasts until 2037, providing approximately 20 years from the filing date.
References
- U.S. Patent and Trademark Office. (2023). Patent full-text and image database. Retrieved from https://patft.uspto.gov
- European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com
- Chinese Patent Office. (2023). CNIPA Patent Search. Retrieved from https://cnipa.gov.cn
